Advertisement

International Journal of Clinical Pharmacy

, Volume 40, Issue 5, pp 1001–1004 | Cite as

Validation of pharmacist–physician collaboration in psychiatry: ‘the Eichberger-model’

  • Martina HahnEmail author
  • Christoph Ritter
  • Sibylle C. Roll
Short Research Report

Abstract

Background Collaboration between physicians and pharmacists can increase medication safety. In the “Eichberger model” a clinical pharmacist is employed and working full time in a psychiatric hospital. Objective The aim of this study was to determine the expected type of expertise from a clinical pharmacist in psychiatry and the acceptance of the pharmacist’s recommendations. Method All email requests to the clinical pharmacist from January 1st to April 30th 2015 were screened retrospectively and type of requester and content of request were extracted. Maintenance rate of drug therapy was analyzed by reviewing patient charts 2 weeks after medication prescription. Results A total of 147 requests were included. 85 (57.8%) requests were from attending physicians and 62 (42.2%) from residents. 82.1% of all physicians were contacting the clinical pharmacist during the study period. Most common reasons for requests were: appropriate drug selection (31.3%), drug interactions (25.2%), possible adverse drug events (17%) and switching drugs (12.2%). The acceptance rate by the physicians was 100%, with an implementation and maintenance rate of both 98.6%. Conclusion We found a high acceptance level of the pharmacist’s recommendations. The pharmacist’s skills were requested by the majority of physicians and included a in a large variety of specific questions. A pharmacist can play an important role to optimize patient care in collaboration with the physician in psychiatry.

Keywords

Clinical pharmacist Collaboration Cooperation Germany Intervention Psychiatry 

Notes

Acknowledgements

We thank Mizgin Ograk for helping with the collection of the data.

Funding

No funding was received.

Conflicts of interest

No conflicts of interest.

References

  1. 1.
    Frontini R, Miharija-Gala T, Sykora J. EAHP survey 2010 on hospital pharmacy in Europe: parts 4 and 5. Clinical services and patient safety. Eur J Hosp Pharm. 2013;20:69–73.CrossRefGoogle Scholar
  2. 2.
    Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:CD008986.PubMedGoogle Scholar
  3. 3.
    Mekonnen AB, McLachlan AJ, Brien JE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6:e010003.CrossRefGoogle Scholar
  4. 4.
    Gallagher J, McCarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36(6):1101–14.CrossRefGoogle Scholar
  5. 5.
    Hahn M, Roll SC. A new approach to pharmaceutical care: experiences with the “Eichberger” Model in a psychiatric clinic in Germany. Drug Ther Perspect. 2012;28(9):24–6.Google Scholar
  6. 6.
    Langebrake C, Hilgarth H. Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci. 2010;32(2):194–9.CrossRefGoogle Scholar
  7. 7.
    Stemer G, Lemmens-Gruber R. The clinical pharmacist’s contributions within the multidisciplinary patient care team of an intern nephrology ward. Int J Clin Pharm. 2011;33(5):759–62.CrossRefGoogle Scholar
  8. 8.
    Wolf C, Pauly A, Mayr A, Grömer T, Lenz B, Kornhuber J, et al. Pharmacist-led medication reviews to identify and collaboratively resolve drug-related problems in psychiatry: a controlled, clinical trial. PLoS One. 2015;10(11):e0142011.CrossRefGoogle Scholar
  9. 9.
    Cortejoso L, Dietz RA, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Clin Interv Aging. 2016;11:1343–50.CrossRefGoogle Scholar
  10. 10.
    Bondesson Å, Holmdahl L, Midlöv P, Höglund P, Andersson E, Eriksson T. Int J Clin Pharm. 2012;34:272.  https://doi.org/10.1007/s11096-012-9609-3.CrossRefPubMedGoogle Scholar
  11. 11.
    Hannou S, Voirol P, Pannatier A, Weibel ML, Sadeghipour F, von Gunten A, Mall JF, De Giorgi Salamun I. Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry. Int J Clin Pharm. 2017;39(6):1228–36.CrossRefGoogle Scholar
  12. 12.
    McDonough RP, Carter BL, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. JAPhA. 2001;41(5):682–92.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Psychiatric HospitalVitos Klinik EichbergEltvilleGermany
  2. 2.Institut für Pharmazie, Klinische PharmazieErnst Moritz, Arndt Universität GreifswaldGreifswaldGermany

Personalised recommendations